Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism

Alzheimer’s disease (AD) is a progressive neurological illness characterized by memory loss and cognitive deterioration. Dapagliflozin was suggested to attenuate the memory impairment associated with AD; however, its mechanisms were not fully elucidated. This study aims to examine the possible mecha...

Description complète

Détails bibliographiques

Auteurs principaux:	Waad A. Samman, Salma M. Selim, Hassan M. El Fayoumi, Norhan M. El-Sayed, Eman T. Mehanna, Reem M. Hazem
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-05-01
Collection:	Pharmaceuticals
Sujets:	Alzheimer’s disease dapagliflozin AMPK pathway oxidative stress glucose metabolism
Accès en ligne:	https://www.mdpi.com/1424-8247/16/5/753
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!